Stock Taper
SCREENER COMPARE ANY 2 STOCKS
LIVN
LIVANOVA PLC
NASDAQ
$80.32
▲ UP 0.36% (0.29)

KEY STATISTICS

Market Cap$4.41 B
52w High$85.76
52w Low$48.82
Dividend Yield—
Frequency—
P/E19.08
Volume465.95K
Shares Out.54.93M

COMPANY

LEADERSHIP

Vladimir A. Makatsaria
CHIEF EXECUTIVE
Vladimir A. Makatsaria

COMPENSATION 2026

Salary$286,826
Stock Awards$4,746,297
Incentive Plan Pay$0
All Other Comp.$1,552,221
Total$8,210,340

ABOUT

SECTOR
Healthcare
WENT PUBLIC
October 19, 2015
METHOD OF GOING PUBLIC
Reverse Merger
FULL TIME EMPLOYEES
3,300

PRICE TARGET

Target High$95.00
Target Low$76.00
Target Median$92.00
Target Consensus$88.20

UPCOMING EARNINGS

DateNov 4, 2026
DayWednesday
Rev. Est.$381.06M
NOV
4
WED

PRICE

$80.32 ▲ UP 0.36% (+$0.29)
$79.50$80.00$80.509:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM80.32

About LivaNova PLC

https://www.livanova.com ↗

LivaNova PLC is a global medical device company specializing in cardiopulmonary, neuromodulation, and circulatory support solutions for healthcare providers, including implantable devices for epilepsy, depression, and heart failure.

INDUSTRY

Medical - Devices

A PRODUCT LIVANOVA PLC IS KNOWN FOR

Essenz Perfusion System
Essenz Perfusion System

A next-generation heart-lung machine that provides a patient-tailored approach to cardiopulmonary bypass procedures. Its recent global launches in major markets highlight it as a key product for LivaNova's current growth.

COMPETITORS

COMPETITOR
ABT COMPARE
BSX COMPARE
EW COMPARE
MDT COMPARE
TFX COMPARE

Revenue by Products

IconPRODUCTQ3-2025Q4-2025Q1-2026Q2-2026
Cardiopulmonary Segment$203.22M $206.57M ▲$208.66M ▲$221.58M ▲
Neuromodulation Segment$149.53M $152.72M ▲$151.79M ▼$166.94M ▲

Revenue by Geography

MapREGIONQ3-2025Q4-2025Q1-2026Q2-2026
UNITED STATES$190.45M $191.49M ▲$184.68M ▼$199.35M ▲
Locations Excluding The United States And Europe$99.62M $94.42M ▼$101.93M ▲$109.42M ▲
Europe$67.68M $75.02M ▲$75.65M ▲$81.82M ▲

ETFS HOLDING THIS STOCK

ETFS HOLDING
204
LISTED HERE
26
RANKED BY POSITION SIZE
XUU.TO
0.01% · 1.9M
AVUV
0.41% · 1.6M
VXF
0.05% · 631.9K
MDY
0.12% · 402.4K
XMHQ
0.53% · 373.5K
SCHA
0.09% · 261.5K
DFAT
0.12% · 213.7K
PSC
0.35% · 121.1K
LFSC
6.63% · 104.6K
FFSM
0.59% · 90.9K
XRSU.L
0.14% · 51.3K
FDLS
0.98% · 30.6K
RSSL
0.14% · 26.8K
WSCSRI.SW
0.16% · 16.9K
GSSC
0.12% · 16.8K
HTEC
1.65% · 16.1K
JHSC
0.18% · 16.1K
JPSE
0.21% · 15.5K
VIRS
0.65% · 15.5K
GOAI.PA
0.09% · 15.2K
SP
SPIT
3.16% · 13.5K
SYZ
0.38% · 3.2K
TILT
0.01% · 3.2K
SMDX
0.15% · 2.5K
URTY
0.06% · 2.3K
BKSE
0.19% · 2.1K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
76.66%
HOLDERS
450
TOP 12 OF 450 · RANKED BY POSITION SIZE
Blackrock, Inc.
7.6M sh · $622.1M
Blackrock Inc.
6.9M sh · $378.49M
Primecap Management Co/Ca/
4.4M sh · $232.82M
Millennium Management LLC
3.5M sh · $214.38M
Fmr LLC
3.1M sh · $258.78M
Hood River Capital Management LLC
2.6M sh · $210.96M
Aqr Capital Management LLC
2.5M sh · $154.38M
Artisan Partners Limited Partnership
2.4M sh · $127.13M
Wellington Management Group Llp
2.3M sh · $122.86M
Vanguard Group Inc
2.3M sh · $143.49M
Invesco Ltd.
2.2M sh · $183.97M
State Street Corp
2.2M sh · $178.1M

RATINGS SNAPSHOT

Overall rating: B+

DCFROEROAD/EP/EP/B
Discounted Cash Flow4
Return On Equity4
Return On Assets4
Debt To Equity2
Price To Earnings2
Price To Book2
Overall Score3

INSIDER TRADES

★
OFFICER: CHIEF INNOVATION OFFICER
Tezel Ahmet
Purchase · 12.7K shares
2026-08-11
★
OFFICER: CHIEF INNOVATION OFFICER
Tezel Ahmet
Sale · 1.4K shares
2026-08-11
★
OFFICER: CHIEF INNOVATION OFFICER
Tezel Ahmet
Sale · 8.6K shares
2026-08-11
★
OFFICER: CHIEF INNOVATION OFFICER
Tezel Ahmet
Sale · 2.7K shares
2026-08-11

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 2
OUTPERFORM 2
OVERWEIGHT 1
EQUAL WEIGHT 1
6 GRADES IN THE LAST 12 MONTHS
Needham BUY Mizuho OUTPERFORM Keybanc OVERWEIGHT Baird OUTPERFORM Barclays EQUAL WEIGHT Stifel BUY

SECTORS PEERS

PEERPRICE
SRRK$57.80COMPARE
HTFL$47.78COMPARE
IDYA$40.11COMPARE
LEGN$19.88COMPARE
IRON$80.03COMPARE
ZLAB$26.08COMPARE
PBH$52.47COMPARE
SGRY$13.69COMPARE